You just read:

Vigilant Biosciences Announces Oral Presentation on Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cancer at the American Academy of Otolaryngology-Head and Neck Surgery Foundation 2016 Annual Meeting

News provided by

Vigilant Biosciences, Inc.

Sep 16, 2016, 10:06 ET